Diagnostyka S.A. (WSE: DIA)
Health Care · Health Care Providers & Services · PL
zł166.50
-1.42% today · -15.5% 1Y
Diagnostyka S.A. (WSE: DIA) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.52B.
Over the last twelve months the share price has lost 15.5%, trading between 146.40 and 219.90.
Tweenvest scores Diagnostyka S.A. across four factors: quality 66/100, value 79/100, dividend 43/100. Its strongest factor is value.
DIA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.52B
- Revenue (TTM)
- $673.94M
- P/E
- 21.51
- EPS
- 7.74
- Dividend yield
- 2.60%
- Beta (5Y)
- —
- 52-week high
- zł219.90
- 52-week low
- zł146.40
- Avg volume (3M)
- —
- Shares outstanding
- 33.76M
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $357.92B | $398.76 | +2.22% |
| CVS Health CorporationNYSE: CVS | $120.36B | $94.11 | +1.17% |
| McKesson CorporationNYSE: MCK | $101.88B | $873.79 | +1.73% |
| HCA Healthcare, Inc.NYSE: HCA | $92.93B | $429.24 | +0.01% |
| Elevance Health, Inc.NYSE: ELV | $87.32B | $402.63 | +0.52% |
| The Cigna GroupNYSE: CI | $74.11B | $280.45 | +1.06% |
| Cencora, Inc.NYSE: COR | $61.78B | $323.77 | +1.80% |
| Cardinal Health, Inc.NYSE: CAH | $54.04B | $232.37 | +1.25% |
Figures last refreshed Aug 18, 2026.